Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on September 19, 2016, reports on an extraordinary general meeting held by Cellect Biotechnology Ltd. on September 18, 2016. The meeting involved ordinary shareholders and holders of American Depositary Shares (ADSs).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance proceedings rather than financial performance.
Material Changes
At the September 18 meeting, ordinary shareholders passed all proposed agenda items. However, the meeting was adjourned for ADS holders only due to a lack of quorum. A reconvened meeting for ADS holders is scheduled for September 25, 2016.
Outlook and Risks
The primary contingency noted is the need to reconvene the meeting for ADS holders to achieve a quorum and vote on the agenda items. No specific financial guidance or management commentary on business outlook is included in this filing.
Key Facts for Investors
- Ordinary shareholders approved all agenda items on September 18, 2016.
- ADS holders failed to achieve a quorum, delaying their vote.
- A follow-up meeting for ADS holders is set for September 25, 2016, at 16:00 in Ramat Gan, Israel.
- No financial data is disclosed in this specific filing.